Evaluation of the Effect of Concurrent Chronic Total Occlusion and Successful Staged Revascularization on Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction
Table 3
Overall 3-year clinical outcomes of patients who underwent primary percutaneous coronary intervention.
Variable
SVD
MVD, no CTO
MVD with CTO
value
( = 595, 47.0%)
( = 519, 41.0%)
( = 152, 12.0%)
MACE
108 (18.2%)
131 (25.2%)
56 (36.8%)
<0.001
Death
26 (4.4%)
44 (8.5%)
27 (17.8%)
<0.001
Cardiac
15 (2.5%)
30 (5.8%)
24 (15.8%)
<0.001
Noncardiac
11 (1.9%)
14 (2.7%)
3 (2.0%)
0.470
Reinfarction
26 (4.4%)
42 (8.1%)
15 (9.9%)
0.009
Ischaemia-driven target vessel revascularization
63 (10.6%)
71 (13.7%)
27 (17.8%)
0.042
Rehospitalization due to heart failure
25 (4.2%)
43 (8.3%)
20 (13.2%)
<0.001
Stroke
9 (1.5%)
10 (1.9%)
5 (3.3%)
0.357
Categorical variables are described as absolute numbers (%) and compared by means of the chi-square test. CTO: chronic total occlusion; PCI: percutaneous coronary intervention; MACE: major adverse cardiac events.
